Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/NRSN/Revenue

NeuroSense Therapeutics Ltd. (NRSN) Revenue

NeuroSense Therapeutics Ltd. (NRSN) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to NRSN

Source: SEC XBRL filings · For reference only · Not investment advice

More NRSN financial trends

NRSN Net incomeNRSN Net marginNRSN Gross profitNRSN Gross marginNRSN Operating incomeNRSN Operating marginNRSN Operating cash flowNRSN Free cash flowNRSN Capital expendituresNRSN Return on equityNRSN Stock buybacksNRSN Dividends paidNRSN Total assetsNRSN Total liabilitiesNRSN Shareholders’ equityNRSN overview →